Stay updated on Elranatamab Combo in Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo in Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added MagnetisMM-6 study details with an open-label, two-arm, multicenter randomized design comparing Elranatamab + Daratumumab + Lenalidomide vs Daratumab + Bortezomib + Lenalidomide + Dexamethasone in transplant-ineligible newly diagnosed multiple myeloma, including Part 1 safety/dose characterization and Part 2 MRD-negative CR rate and PFS endpoints, and noted 89 locations. Deleted the earlier version that described the trial as transplant-ineligible or transplant-deferred participants with slightly different wording and site count (88 vs 89), reflecting updated eligibility scope and site count.
    Difference
    1%
    Check dated 2026-04-17T02:50:02.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Removed the core disease term 'Multiple myeloma' and a related MedlinePlus Genetics topic, reducing essential context about the study's focus.
    Difference
    0.1%
    Check dated 2026-04-09T21:47:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added topic tags for 'Multiple myeloma' and the related topic 'MedlinePlus Genetics' to the study page to improve categorization and link to educational resources.
    Difference
    0.1%
    Check dated 2026-04-02T15:38:03.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Epworth Healthcare Richmond, Richmond, Victoria, Australia as a study site. Removed Incheon, South Korea locations and associated Not yet recruiting status, along with several related topics.
    Difference
    0.4%
    Check dated 2026-03-26T11:46:03.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.0%
    Check dated 2026-03-19T06:22:44.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Related topic tags for Multiple myeloma and MedlinePlus Genetics were added, and the site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:27:54.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo in Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo in Myeloma Clinical Trial page.